$2.27T
Total marketcap
$127.62B
Total volume
BTC 49.78%     ETH 15.69%
Dominance

Utah Medical Products, Inc. UTM.F Stock

65.5 EUR {{ price }} 0.769231% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
235.08M EUR
LOW - HIGH [24H]
65.5 - 65.5 EUR
VOLUME [24H]
50 EUR
{{ volume }}
P/E Ratio
15.37
Earnings per share
4.26 EUR

Utah Medical Products, Inc. Price Chart

Utah Medical Products, Inc. UTM.F Financial and Trading Overview

Utah Medical Products, Inc. stock price 65.5 EUR
Previous Close 88.5 EUR
Open 86.5 EUR
Bid 86.5 EUR x N/A
Ask 87.5 EUR x N/A
Day's Range 86.5 - 86.5 EUR
52 Week Range 79 - 97.5 EUR
Volume 200 EUR
Avg. Volume 7 EUR
Market Cap 313.83M EUR
Beta (5Y Monthly) 0.194366
PE Ratio (TTM) 19.52596
EPS (TTM) 4.26 EUR
Forward Dividend & Yield 1.07 (1.16%)
Ex-Dividend Date June 15, 2023
1y Target Est N/A

UTM.F Valuation Measures

Enterprise Value 255.01M EUR
Trailing P/E 19.52596
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 5.9801836
Price/Book (mrq) 2.6591656
Enterprise Value/Revenue 4.859
Enterprise Value/EBITDA 9.203

Trading Information

Utah Medical Products, Inc. Stock Price History

Beta (5Y Monthly) 0.194366
52-Week Change 14.90%
S&P500 52-Week Change 20.43%
52 Week High 97.5 EUR
52 Week Low 79 EUR
50-Day Moving Average 86.62 EUR
200-Day Moving Average 87.46 EUR

UTM.F Share Statistics

Avg. Volume (3 month) 7 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 3.63M
Float 3.19M
Short Ratio N/A
% Held by Insiders 6.46%
% Held by Institutions 72.53%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.17
Trailing Annual Dividend Yield 1.32%
5 Year Average Dividend Yield N/A
Payout Ratio 0.24790001
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 32.68%
Operating Margin (ttm) 39.49%
Gross Margin 61.94%
EBITDA Margin 52.80%

Management Effectiveness

Return on Assets (ttm) 10.46%
Return on Equity (ttm) 15.10%

Income Statement

Revenue (ttm) 52.48M EUR
Revenue Per Share (ttm) 14.46 EUR
Quarterly Revenue Growth (yoy) 1.60%
Gross Profit (ttm) 32.2M EUR
EBITDA 27.71M EUR
Net Income Avi to Common (ttm) 17.15M EUR
Diluted EPS (ttm) 4.43
Quarterly Earnings Growth (yoy) 19.19%

Balance Sheet

Total Cash (mrq) 80.91M EUR
Total Cash Per Share (mrq) 22.3 EUR
Total Debt (mrq) 328K EUR
Total Debt/Equity (mrq) 0.28 EUR
Current Ratio (mrq) 15.659
Book Value Per Share (mrq) 32.529

Cash Flow Statement

Operating Cash Flow (ttm) 23.02M EUR
Levered Free Cash Flow (ttm) 18.94M EUR

Profile of Utah Medical Products, Inc.

Country Germany
State UT
City Midvale
Address 7043 South 300 West
ZIP 84047-1048
Phone 801 566 1200
Website https://www.utahmed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 186

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Q&A For Utah Medical Products, Inc. Stock

What is a current UTM.F stock price?

Utah Medical Products, Inc. UTM.F stock price today per share is 65.5 EUR.

How to purchase Utah Medical Products, Inc. stock?

You can buy UTM.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Utah Medical Products, Inc.?

The stock symbol or ticker of Utah Medical Products, Inc. is UTM.F.

Which industry does the Utah Medical Products, Inc. company belong to?

The Utah Medical Products, Inc. industry is Medical Instruments & Supplies.

How many shares does Utah Medical Products, Inc. have in circulation?

The max supply of Utah Medical Products, Inc. shares is 3.59M.

What is Utah Medical Products, Inc. Price to Earnings Ratio (PE Ratio)?

Utah Medical Products, Inc. PE Ratio is 15.37558600 now.

What was Utah Medical Products, Inc. earnings per share over the trailing 12 months (TTM)?

Utah Medical Products, Inc. EPS is 4.26 EUR over the trailing 12 months.

Which sector does the Utah Medical Products, Inc. company belong to?

The Utah Medical Products, Inc. sector is Healthcare.